EFFICACY, TOLERANCE AND HORMONAL EFFECTS OF A NEW ORAL ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, RAMIPRIL (HOE 498), IN MILD TO MODERATE PRIMARY HYPERTENSION

被引：15
作者：
KARLBERG, BE [1 ]
LINDSTROM, T [1 ]
ROSENQVIST, U [1 ]
OHMAN, KP [1 ]
机构：
[1] LINKOPING UNIV HOSP,CLIN RES CTR,S-58185 LINKOPING,SWEDEN
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1987年 / 59卷 / 10期
关键词：
D O I：
10.1016/0002-9149(87)90063-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：D104 / D109
页数：6
相关论文
共 50 条
  • [21] HEMODYNAMIC AND HUMORAL EFFECTS OF ORAL PERINDOPRIL, AN ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, IN MAN
    LEES, KR
    REID, JL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (02) : 159 - 164
  • [22] EFFECTS OF THE NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, RAMIPRIL, IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    STUMPE, KO
    OVERLACK, A
    KOLLOCH, R
    SCHATZ, J
    WITTE, PU
    PAHNKE, K
    KLINISCHE WOCHENSCHRIFT, 1986, 64 (12): : 558 - 562
  • [23] TREATMENT OF MILD-TO-MODERATE CONGESTIVE-HEART-FAILURE WITH THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR QUINAPRIL
    SARDU, G
    ADVANCES IN THERAPY, 1991, 8 (03) : 124 - 132
  • [24] EFFECTS ON AUTONOMIC FUNCTION OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, RAMIPRIL
    SUGIMOTO, K
    KUMAGAI, Y
    TATEISHI, T
    SEGUCHI, H
    EBIHARA, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S40 - S45
  • [25] SYMPOSIUM - RAMIPRIL - A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, BRUSSELS, MAY 2-4, 1986 - INTRODUCTION
    ROBERTSON, JIS
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (10) : D1 - D2
  • [26] EFFECTS OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR RAMIPRIL DURING ACUTE ISCHEMIC LEFT-VENTRICULAR FAILURE IN DOGS
    SCHOLKENS, BA
    MARTORANA, PA
    GOBEL, H
    GEHRING, D
    ZEITSCHRIFT FUR KARDIOLOGIE, 1986, 75 : 39 - 39
  • [27] ANTIHYPERTENSIVE, ENZYMATIC, AND HORMONAL ACTIVITY OF CILAZAPRIL, A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION
    SANCHEZ, RA
    TRABALLI, CA
    BARCLAY, CA
    GILBERT, HB
    MUSCARA, M
    GIANNONE, C
    MOLEDO, LI
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (02) : 230 - 234
  • [28] Coadministration of eplerenone with an angiotensin converting enzyme inhibitor or an angiotensin II blocker in patients with mild to moderate hypertension
    Krum, H
    Nolly, H
    Roniker, B
    Fakouhi, K
    Krause, S
    Fleming, C
    EUROPEAN HEART JOURNAL, 2001, 22 : 612 - 612
  • [29] THE EFFECTS OF BENAZEPRIL, A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN MILD TO MODERATE ESSENTIAL-HYPERTENSION - A MULTICENTER STUDY
    MOSER, M
    ABRAHAM, PA
    BENNETT, WM
    BRACHFELD, N
    GOODMAN, RP
    MCKENNEY, JM
    HOLLIFIELD, JW
    KIRKENDALL, WM
    LASSETER, KC
    LEON, AS
    LUNN, JA
    MILLER, K
    MORGANROTH, J
    RUDDY, MC
    SAMBHI, MP
    STEIN, WJ
    WEBER, MA
    WILLIAMS, RL
    ZAWADA, ET
    DESILVA, J
    GOURLEY, LA
    WHALEN, JJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (03) : 322 - 329
  • [30] EFFICACY OF AN ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR (CAPTOPRIL) IN SEVERE HYPERTENSION
    ZWEIFLER, AJ
    JULIUS, S
    NICHOLLS, MG
    CLINICAL RESEARCH, 1979, 27 (02): : A320 - A320
12345